EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 18 filers reported holding EVOFEM BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,000 | – | 18,500 | +3600.0% | 0.00% | – |
Q4 2021 | $0 | – | 500 | -3.8% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 520 | -97.0% | 0.00% | – |
Q2 2021 | $19,000 | +11.8% | 17,130 | +82.6% | 0.00% | – |
Q1 2021 | $17,000 | -43.3% | 9,379 | -23.8% | 0.00% | – |
Q4 2020 | $30,000 | +57.9% | 12,312 | +53.5% | 0.00% | – |
Q3 2020 | $19,000 | -20.8% | 8,021 | -6.9% | 0.00% | – |
Q2 2020 | $24,000 | +200.0% | 8,616 | +487.3% | 0.00% | – |
Q1 2020 | $8,000 | -11.1% | 1,467 | -1.3% | 0.00% | – |
Q4 2019 | $9,000 | +200.0% | 1,487 | +181.6% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 528 | +5.6% | 0.00% | – |
Q2 2019 | $3,000 | -25.0% | 500 | -50.4% | 0.00% | – |
Q1 2019 | $4,000 | 0.0% | 1,008 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | 0.0% | 1,008 | +0.8% | 0.00% | – |
Q3 2018 | $4,000 | +33.3% | 1,000 | -0.1% | 0.00% | – |
Q2 2018 | $3,000 | +50.0% | 1,001 | +266.7% | 0.00% | – |
Q1 2018 | $2,000 | – | 273 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,100,000 | $812,000 | 0.27% |
Westside Investment Management, Inc. | 10,000 | $7,230,000 | 0.02% |
Baker Brothers Advisors | 2,697,110 | $1,992,000 | 0.01% |
Bedel Financial Consulting, Inc. | 22,500 | $17,000 | 0.01% |
Congress Park Capital LLC | 14,500 | $11,000 | 0.01% |
Callan Capital, LLC | 50,000 | $37,000 | 0.01% |
FULLER & THALER ASSET MANAGEMENT, INC. | 1,079,860 | $798,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 60,381 | $45,000 | 0.01% |
Platform Technology Partners | 13,000 | $10,000 | 0.01% |
JB CAPITAL PARTNERS LP | 23,184 | $17,000 | 0.00% |